Logo
x

Search

Subscribe Now

South Korea

Antengene Reports NDA Submission for ATG-010 (selinexor) to Treat RRMM and RR DLBCL in South Korea

Antengene Reports NDA Submission for ATG-010 (selinexor) to Treat RRMM and RR DLBCL in South Korea

  • January 4, 2021
Celltrion Initiates P-I Study of its COVID-19 Antibody Treatment in South Korea

Celltrion Initiates P-I Study of its COVID-19 Antibody Treatment in South Korea

  • July 20, 2020
Samsung Launches a Blood Pressure Monitoring App in South Korea

Samsung Launches a Blood Pressure Monitoring App in South Korea

  • June 18, 2020
Inovio to Initiate P-I/II Study of INO-4800 Against COVID-19 in South Korea

Inovio to Initiate P-I/II Study of INO-4800 Against COVID-19 in South Korea

  • June 4, 2020
Mundipharma Signs an Exclusive Commercialization and Distribution Agreement with Biosolution in South Korea

Mundipharma Signs an Exclusive Commercialization and Distribution Agreement with Biosolution in South Korea

  • January 7, 2020
Ono Pharmaceutical Signs an Exclusive License Agreement with Forty Seven to Develop and Commercialize 5F9 in Selected Asian Countries

Ono Pharmaceutical Signs an Exclusive License Agreement with Forty Seven to Develop and Commercialize 5F9 in Selected Asian Countr...

  • July 12, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.